Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Immunotherapy approaches for pancreatic ductal adenocarcinoma (PDAC) have met with limited success. It has been postulated that a low mutation load may lead to a paucity of T cells within the tumor microenvironment (TME). However, it is also possible that while neoantigens are present, an effective immune response cannot be generated due to an immu...
Alternative Titles
Full title
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071896
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5071896
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep35848
